Find Tenders for Medical equipments, pharmaceuticals and personal care products

RSV immunisation products - Adults

Description: RSV immunisation products - Adults (2028)

Summary: The upcoming procurement process led by the Secretary of State for Health and Social Care, in collaboration with the UK Health Security Agency, focuses on acquiring RSV immunisation products for adults. This opportunity falls within the pharmaceuticals sector, specifically focusing on vaccines. Based in London, the procurement process is currently in the planning stage. Key dates to note include the planned contract period starting on 30th June 2028 and ending on 29th June 2030, with a future notice due to be communicated by 1st March 2027. The procurement is guided by the legal framework stated in legislation 2023/54 and is classified under the main category of goods.

Meningococcal ACWY vaccine (2027)

Description: Meningococcal ACWY vaccine supply (2027)

Summary: The Secretary of State for Health and Social Care, acting through the UK Health Security Agency, is currently in the planning phase for a procurement process concerning the Meningococcal ACWY vaccine for the year 2027. This procurement is categorized under the goods industry, specifically for vaccines, and is planned to span from 1st August 2027 to 31st July 2029. The main location for this procurement is London, UK, with communications from the procurement office facilitated via procurementnotices@ukhsa.gov.uk. A future notice concerning the procurement will be published on 26th May 2026. This planned procurement is detailed in a pipeline notice published on the Find a Tender service.

Measles, Mumps and Rubella (MMR) vaccine

Description: Measles, Mumps and Rubella (MMR) vaccine (2027)

Summary: The procurement process initiated by the Secretary of State for Health and Social Care, acting through the UK Health Security Agency, is currently in the planning stage for the acquisition of the Measles, Mumps, and Rubella (MMR) vaccine. The procurement is classified under the goods category within the vaccine industry sector. The main procurement activity is centred around London, with operations carried out at the UK Health Security Agency's office located at 10 South Colonnade, London, E14 4PU. The planned release of a future notice is set for 19 June 2026, with the contract projected to commence on 1 May 2027 and run until 30 September 2029. This forms part of the Crown's strategic buying action under legal basis legislation 2023/54.

Smallpox Vaccine

Description: Vaccine for prevention of Smallpox

Summary: The Secretary of State for Health and Social Care, through the UK Health Security Agency, is planning a procurement process for the acquisition of a smallpox vaccine, classified under the public authority central government. This tender, titled "Smallpox Vaccine," falls within the goods category, specifically under CPV code 33651600 for vaccines, and is currently in the planning stage as of 22 May 2026. The procurement process is initiated as a tender, with a related lot set to commence on 11 January 2027 and conclude on 10 January 2031. The anticipated communication for future notices is scheduled for 27 July 2026. The agency is located at 10 South Colonnade, London, and any inquiries can be directed to procurementnotices@ukhsa.gov.uk.

RSV immunisation products - Infants

Description: RSV immunisation products - Infants (2028)

Summary: The procurement process, led by the Secretary of State for Health and Social Care acting as part of the Crown through the UK Health Security Agency, is in the planning stage for acquiring "RSV immunisation products - Infants" targeted for delivery in 2028. This process is categorised under goods, specifically focusing on vaccines, and it is being managed from the UK Health Security Agency's offices in London. A significant date to note is 1st March 2027, when further notice regarding this tender is expected. The contract period is projected from 30th June 2028 to 29th June 2030, highlighting a long-term engagement opportunity.

Meningococcal ACWY vaccine (2027)

Description: Pneumococcal conjugate vaccine (PCV20) for adults and at risk (2027)

Summary: The procurement process is being initiated by the Secretary of State for Health and Social Care, acting through the UK Health Security Agency, located at 10 South Colonnade, London, E14 4PU, United Kingdom. The tender, titled "Meningococcal ACWY vaccine (2027)", is categorised under the goods industry, specifically focusing on vaccines, with a CPV code of 33651600. This process is currently in the planning stage and anticipates a start date for the contract on 1st May 2027, extending to 30th April 2029. Key forthcoming communications are scheduled for 30th October 2026. This is a planned procurement under the UK Health Security Agency, classified as a public authority within the central government category.

Culture media in UKHSA regional and reference laboratories

Description: Culture media in UKHSA regional and reference laboratories procurement 2026

Summary: The public procurement process currently in the planning stage is being conducted by the UK Health Security Agency on behalf of the Secretary of State for Health and Social Care. The procurement, titled "Culture media in UKHSA regional and reference laboratories," is focused on acquiring reagents and contrast media within the goods industry category. The contract's location is in London, United Kingdom, with a planning notice published on 22nd May 2026. The anticipated contract period spans from 12th August 2026 to 11th August 2031. Business users should mark 1st July 2026 as the date for future notice clarifications related to this tender. This procurement is guided by the legal framework specified in the UKPGA 2023/54, employing a procurement process tailored for central government public authorities.

Enteral Nutrition, Pumps, Associated Maintenance, Consumables and Home Delivery Service

Description: For the supply of Enteral Nutrition, Pumps, Associated Maintenance, Consumables and Home Delivery Service

Summary: The procurement process initiated by Sheffield Teaching Hospitals NHS Foundation Trust, titled "Enteral Nutrition, Pumps, Associated Maintenance, Consumables, and Home Delivery Service", is in the Planning stage. This tender is focused on goods related to enteral feeds, and the procurement process will proceed via an open procedure. The geographical location is Sheffield, United Kingdom, and the contract period is planned to start on 1st June 2027 and end on 31st May 2031, with a potential extension to 31st May 2033. A significant gross budget of £21,486,153.60 is allocated for this procurement. Interested parties should note that a future notice is expected by 28th September 2026.

LSL/MED/0246 The Supply of Tranexamic Acid Auto-Injector (TXA AI)

Description: LSL/MED/0246 Procurement description Provide sufficient information to understand the scope of the procurement. In April 2015 the MOD signed a thirteen year contract with Leidos Europe Ltd to provide the procurement and inventory management of commodity items (as well as the storage and distribution services) historically provided in-house by the Logistic Commodities and Services Operating Centre. Leidos, working with the MOD, will transform the way these services are delivered to ensure requirements continue to be met whilst providing best value for money for the department. The organisation delivering these services is known as Team Leidos. Team Leidos would like to make markets aware that we are intending to investigate innovative approaches to fill our Supply of Tranexamic Acid Auto-Injector (TXA AI) requirements. We are actively seeking innovative, commercially (read more...)

Summary: The procurement process for the supply of Tranexamic Acid Auto-Injector (TXA AI) is currently in the planning stage, managed by Leidos Supply Limited, a central government authority based in Bristol, United Kingdom. The procurement is intended to source innovative, commercially viable solutions for an auto-injector device containing 1g of Tranexamic Acid in no greater than 3ml volume. The estimated framework value falls between £4,000,000 and £5,000,000. A preliminary market engagement notice (PMEN) has been issued to understand market innovations and inform future strategies. The deadline for submitting PMEN documents is set for 27 July 2026, with further procurement notifications anticipated by 16 November 2026. Delivery is expected across the United Kingdom for various medicinal products under the main procurement category of goods. The planned contract period spans from 21 May 2027 to 20 May 2031.

LSL/MED/0246 The Supply of Tranexamic Acid Auto-Injector (TXA AI)

Description: LSL/MED/0246 Procurement description Provide sufficient information to understand the scope of the procurement. In April 2015 the MOD signed a thirteen year contract with Leidos Europe Ltd to provide the procurement and inventory management of commodity items (as well as the storage and distribution services) historically provided in-house by the Logistic Commodities and Services Operating Centre. Leidos, working with the MOD, will transform the way these services are delivered to ensure requirements continue to be met whilst providing best value for money for the department. The organisation delivering these services is known as Team Leidos. Team Leidos would like to make markets aware that we are intending to investigate innovative approaches to fill our Supply of Tranexamic Acid Auto-Injector (TXA AI) requirements. We are actively seeking innovative, commercially (read more...)

Summary: The procurement process for the supply of Tranexamic Acid Auto-Injector (TXA AI) is currently in the planning stage, managed by Leidos Supply Limited, a central government authority based in Bristol, United Kingdom. The procurement is intended to source innovative, commercially viable solutions for an auto-injector device containing 1g of Tranexamic Acid in no greater than 3ml volume. The estimated framework value falls between £4,000,000 and £5,000,000. A preliminary market engagement notice (PMEN) has been issued to understand market innovations and inform future strategies. The deadline for submitting PMEN documents is set for 27 July 2026, with further procurement notifications anticipated by 16 November 2026. Delivery is expected across the United Kingdom for various medicinal products under the main procurement category of goods. The planned contract period spans from 21 May 2027 to 20 May 2031.